Drug Profile
Hydrochlorothiazide/metoprolol succinate - AstraZeneca
Alternative Names: DUTOPROLLatest Information Update: 04 Apr 2019
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antihypertensives; Benzothiadiazines
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Thiazide diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 28 Feb 2014 Covis enters into an asset purchase agreement with AstrZeneca for acquiring hydrochlorothiazide/metoprolol succinate (Covis Form 51-102F4, July 2015)
- 12 Apr 2012 Launched for Hypertension in USA (PO)
- 28 Aug 2006 Registered for Hypertension in USA (PO)